What do You Think of CPhI? - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

What do You Think of CPhI?

CPhI 2012 will draw to a close later today in Madrid. the PharmTech team hope you had a successful show!

Throughout the week, we have been asking what you thought of this year's event. Here is a quick selection are some of the comments we received:

"Very busy show, but very successful and lovely warm weather."

"Crowded, but that's to be expected. Very spread out but meetings have been a success."

"Good foot fall at our stand and great response to our products. The invstment has paid off."

"My first CPhI; very overwhelming and much busier than I expected!"

"It's been successful, as usual for our company, but I'm looking forward to going home."

You can keep up to date with any last minute news and announcements via our Twitter feed @PharmTechGroup.

Or take a look at our archive of CPhI news and announcmenets here.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here